125 related articles for article (PubMed ID: 8270966)
1. Intravesical therapy for superficial bladder cancer: is it a wash?
Kilbridge KL; Kantoff P
J Clin Oncol; 1994 Jan; 12(1):1-4. PubMed ID: 8270966
[No Abstract] [Full Text] [Related]
2. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
[TBL] [Abstract][Full Text] [Related]
3. [Superficial bladder cancer: prophylaxis of recurrence and progression].
Miyanaga N; Akaza H; Koiso K
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
[TBL] [Abstract][Full Text] [Related]
4. Intravesical mitozantrone in recurrent superficial bladder cancer.
Newling DW
Br J Urol; 1995 Dec; 76(6):814. PubMed ID: 8535743
[No Abstract] [Full Text] [Related]
5. [Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer].
Chinese Urological Oncology Group
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):42-45. PubMed ID: 30678415
[TBL] [Abstract][Full Text] [Related]
6. Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study.
Stavropoulos NE; Hastazeris K; Filiadis I; Mihailidis I; Ioachim E; Liamis Z; Kalomiris P
Scand J Urol Nephrol; 2002; 36(3):218-22. PubMed ID: 12201939
[TBL] [Abstract][Full Text] [Related]
7. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?].
Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF
Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933
[No Abstract] [Full Text] [Related]
8. Prophylactic treatment of superficial bladder tumor.
Lee C; Park MS
Int J Urol; 1998 Nov; 5(6):511-20. PubMed ID: 9855117
[No Abstract] [Full Text] [Related]
9. Quality of life in patients undergone oncopreventive intravesical treatment for superficial bladder cancer.
Abbona A; Morabito F; Rossi R; Billia M; Liberale F; Ferrando U
Arch Ital Urol Androl; 2007 Dec; 79(4):143-6. PubMed ID: 18303728
[TBL] [Abstract][Full Text] [Related]
10. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
van der Meijden AP
Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
[No Abstract] [Full Text] [Related]
11. [Effect of prophylactic intravesical instillation of pirarubicin to prevent recurrent bladder tumors following nephroureterectomy for upper urinary tract cancer].
Nagashima M; Araki A; Yanagisawa M; Komiya A; Takano T; Murakami T; Ikeda I
Hinyokika Kiyo; 2013 Apr; 59(4):213-6. PubMed ID: 23635455
[TBL] [Abstract][Full Text] [Related]
12. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
13. [Oral administration of 5-fluorouracil (5-FU) with intravesical chemotherapy as prophylaxis against recurrence of superficial bladder tumors].
Tanaka T; Yuasa M; Yamamoto A; Kawanishi Y; Numata A; Imagawa A
Gan No Rinsho; 1986 Sep; 32(11):1439-42. PubMed ID: 3773272
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical chemotherapy of superficial bladder tumors].
Matsumura Y
Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
[TBL] [Abstract][Full Text] [Related]
15. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
Colombo R
Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
[No Abstract] [Full Text] [Related]
16. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
Hinotsu S; Akaza H; Ohashi Y; Kotake T
Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
[TBL] [Abstract][Full Text] [Related]
17. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
18. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
Mouracade P
J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904
[No Abstract] [Full Text] [Related]
19. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
Ayres BE; Crew JP;
BJU Int; 2010 Feb; 105 Suppl 2():14-7. PubMed ID: 20089093
[No Abstract] [Full Text] [Related]
20. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]